Accounts and funds advised by T. Rowe Price Associates, Inc. and Baillie Gifford join syndicate of investors Funding to accelerate commercial launch of revolutionary enzymatic DNA printing technology SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its Series C financing, […]
eureKARE participatesin DNA Script’s $200 Million Series C Financing Fundraisewill accelerate commercial launch of revolutionary enzymatic DNA printing technology Luxembourg and Paris, France – eureKARE (“the Company”), a pioneering company focused on financing and building next generation biotechnology companies in the disruptive fields of the microbiome and synthetic biology, is pleased to announce that it has participated in DNA Script’s […]
CAMBRIDGE, Mass. — Erbi Biosystems, developer of innovative, small-scale, automated, and high-performance cell culture systems, has closed a private round of funding totaling $4M. This latest financing will enable the company to expand operations to meet the growing demand for its Breez perfusion bioreactor product and develop extensions to enhance cell therapy applications. The Erbi Breez bioreactor provides […]
OKLAHOMA CITY — Cortado Ventures is pleased to announce it closed a Pre-Series A investment with an innovative analytical instrument company. Headquartered in Denver, Exum Instruments brings high-performance, solid-sample chemical characterization out of the traditional laboratory environment. This funding milestone closed alongside Alchemy Capital, will enable Exum to lead the company and their first product, the Massbox, […]
The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. — Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A […]
Nicoya’s Series A Extension is led by Whitecap Venture Partners, with participation from industry leader Agilent Technologies Inc (NYSE: A) KITCHENER, Ontario–Nicoya Lifesciences, a global leader in digital proteomics solutions, today announced a $20 million Series A extension led by Whitecap Venture Partners. The round included participation from strategic investor Agilent Technologies, a leading global […]
Company aims to democratise access to affordable biomedical research especially in cancer research and new drug development through its novel 3D cell culture platform Sydney, Australia — Inventia Life Science, a world leader in advanced 3D cell cultures for research and clinical purposes, has today announced the close of a AU$35m Series B funding round, led by Blackbird […]
The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples – Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. — Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A financing […]
– The financing will support development of a commercial instrument system based on the company’s proprietary and disruptive MAGNA™ technology. – MAGNA™ is set to unlock the field of dynamic genomics. – Funds raised from a global investor syndicate led by Lansdowne Partners and Bpifrance and supported by funds bringing additional experience in the life […]
In fiscal year 2020/21, ZEISS achieves highest revenue yet in its 175-year history at 7.5 billion euros (+20% compared to prior year) – including EBIT at 1.5 billion euros (+ 557 m euros as compared to prior year) All four ZEISS segments achieve double-digit revenue growth Significant investments in research and development pay off – […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
